The oncoprotein inhibitory member of the ASPP family (iASPP) is a key inhibitor of the tumor suppressor p53 in various cancers, including prostate cancer [36], liver cancer [37], lung cancer [38] and glioma [39]. This evidence concerns the gene TP53 and central nervous system cancer.